Ōmcare has been named a finalist in the Accenture HealthTech Innovation Challenge, which brings together leading-edge startups with prominent health companies to tackle some of North America’s greatest health challenges.
Attracting more than 2,600 startup applicants in the past five years, the Accenture HealthTech Innovation Challenge supports finding innovative approaches and solutions to help create better healthcare access, experiences and ultimately outcomes for all people.
“We are thrilled to be named a finalist and recognized as a company poised to transform how care is delivered in the home. Ōmcare is committed to helping seniors age where and how they want, lower the cost of care, and enable better outcomes. It’s an honor to be included with seven other companies who are as committed to innovation,” said Lisa Lavin, CEO and Founder.
“The finalists are emerging businesses that are reimagining the healthcare experience to provide people with the convenience and personalization they are accustomed to receiving with other industries,” said Brian Kalis, managing director of digital health and innovation services at Accenture.
The finalists are:
The finalists will participate in the final round and awards ceremony at a virtual event to be held on September 28, 2021. The judging panel will comprise executives from globally recognized health and venture capital companies, providing the finalists with exposure and access to industry-leading experience to help bring their ideas to market.
About Ōmcare
Ōmcare is a digital health company pioneering an open access, home health platform that allows healthcare organizations to extend care into the home via a secure telehealth infrastructure and integration with their patented medication dispensing technology. Based in Burnsville, MN, Ōmcare enables remote delivery of wrap around care coordination and integration of existing virtual care and remote patient care solutions, promising real medication adherence defined as right med, right time, right person. Ōmcare is currently in pilot and experiencing promising results.
